Rising levels of ‘forever chemical' TFA found in European wines
Increasing levels of the trifluoroacetic acid (TFA) 'forever chemical' have been detected in European wines produced since 2010, according to new research.
The 'Message in a Bottle' study, published by non-profit group Pesticide Action Network Europe (PAN Europe), assessed 49 old and "recent" wines harvested between 1974 and 2024.
Wines from 10 EU countries were analysed, including Austria, France, Germany, Hungary, Italy, Spain, Belgium and Sweden.
TFA is part of the family of chemicals known as PFAS , or per- and polyfluoroalkyl synthetic compounds.
The substance was not detected in wines produced before 1988, but wines made since 2010 showed a "sharp increase" in contamination, PAN Europe said.
Wines produced specifically between 2021-2024, or recent wines, contained an average level of 122 micrograms per litre, with some reaching more than 300 micrograms per litre.
Average TFA levels varied across the wines, but all countries assessed had wines containing TFA levels "several orders of magnitude higher than the already high background levels in water", the study found, with wines from Austria being "particularly affected".
Helmut Burtscher-Schaden, environmental chemist at Austrian environmental organisation Global 2000 and the study's "initiator", described the findings as "alarming in two respects" - the first being that they point to significant bioaccumulation of the TFA forever chemical in plants, and the second "more concerning" factor being the increase in TFA contamination since 2010.
"We are likely ingesting significantly more TFA through our diet than previously assumed," he said.
"Urgent action is needed to stop further TFA emissions into the environment."
Policy officer at PAN's European branch, Salome Roynel, called the latest discovery "a clear wake-up call for the EU".
She added: "Substances that release TFA into the environment must be removed from the market without delay. This must start with an immediate ban on all PFAS pesticides - a direct and easily preventable source of TFA pollution - along with a ban on F-gases.'
EU member states are due to vote on a European Commission proposal to ban a PFAS pesticide called flutolanil, which releases TFA, next month, according to Roynel.
'We hope they understand that this is a decisive moment for the future of our water, our food, and ultimately our health, and vote to support its ban."
Just Drinks has contacted European wine trade body the Comité Européen des Entreprises Vins (CEEV) for comment.
A study published in July also found large quantities of the PFAS forever chemicals in humans consuming white rice, eggs, red meat, seafood and coffee.
Posted on Elsevier's Science Direct website, the research looked into dietary sources of PFAS and found high levels in blood and breast milk samples from more than 1,500 mothers in New Hampshire in the US collected since 2009.
"Rising levels of 'forever chemical' TFA found in European wines – study" was originally created and published by Just Drinks, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


San Francisco Chronicle
14 hours ago
- San Francisco Chronicle
Letters: He overdosed after being turned away by S.F. drug treatment center. Mother seeks answers
Jonathan Martin, my son, overdosed after he was turned away from HealthRight360's detox facility on Aug. 27, 2024. Jonathan was desperately ill and seeking help. He died alone early the next morning. Jonathan's death was the subject of a Chronicle story ('He overdosed waiting for help. Why did S.F.'s largest drug treatment center provider turn him away?' San Francisco, Feb. 27). When the story was published, I sent a letter to Mayor Daniel Lurie, District Attorney Brooke Jenkins, the chiefs of the Department of Public Health and relevant agencies, HealthRight360 CEO Vitka Eisen and every member of the Board of Supervisors, hoping to find out why my son was turned away. I wanted to understand what prevented him from receiving the services he so urgently needed. I have still not received a single response, explanation or even a note of condolence from any of these officials. If the people who oversee drug treatment in the city will not answer a grieving mother, who will give my family answers? Citizens of San Francisco: You voted these people into office. Is this how you want your loved one to be treated while trying to seek help? The silence from those in power is deafening. Our family demands answers. Carolyn Stueve-Martin, Tulsa, Okla. Don't hide Pride I empathize with her desire for concealment, misdirection or camouflage during a time of danger. My wife is trans, and this is a scary time for us. But I am afraid that Judd is missing the purpose of Pride entirely. Pride is not about shame. It's not about showing off our most socially acceptable community members in the hopes that bigots will leave the rest alone. It is the bigots who should be ashamed. A Pride celebration that is ashamed of its trans and genderqueer members — who are, as Judd wrote, just people trying to live their lives openly and freely — is no Pride at all. Amanda Seyfer, Oakland Big Brother rising Technology has always been a double-edged sword. Fire can provide warmth and light, but it can also be used to burn down an enemy village. IBM's punch cards helped make Social Security possible, but also enabled Hitler's destruction of European Jewry. Today, a shadowy Bay Area company called Palantir is coalescing federal government information on Americans into a database that would allow it to target anyone who dissents from its autocratic policies or has characteristics that it does not favor. We need our representatives (or the courts) to block this monstrous machine before it rolls over us and makes this country a new Reich just like the old Reich.
Yahoo
2 days ago
- Yahoo
European Mars orbiter spies crumbling crater 'soaked in layers of Martian history' (photo)
When you buy through links on our articles, Future and its syndication partners may earn a commission. A European Mars probe captured a stunning view of a Martian crater that's rich in many of the features that help scientists reconstruct the planet's dynamic history over billions of years. The image, taken in October 2024 using the High Resolution Stereo Camera (HRSC) on the European Space Agency's (ESA) Mars Express orbiter, shows a crumbling crater called Deuteronilus Cavus. It is "soaked in layers of Martian history," having been exposed to volcanic lava flows, erosion from liquid water, repeated freeze-thaw cycles that expanded its edges, and layers of wind-blown volcanic dust settling over time, according to a statement from the space agency. Located in a transitional zone between the planet's rugged southern highlands and smoother northern lowlands, Deuteronilus Cavus is believed to originally have formed following an impact roughly 4.1 to 3.7 billion years ago, when Mars and other planets were being bombarded by huge numbers of asteroids and comets. Over time, the nearly circular 75-mile-wide (120 kilometers) depression has been eroded by water and ice, enlarging it to nearly twice its initial size. ESA shared a fun "recipe" outlining the series of events that shaped the crater, offering valuable insights into the planet's climatic and geological evolution. For example, the presence of clay minerals indicates past interactions between volcanic materials and water, hinting at the possibility of ancient habitable environments, according to the statement. This is further supported by channels cut through the crater's rim, likely formed by surface water flow or the collapse of weakened ground above draining subsurface water. Meanwhile, grooves in the crater rim suggest that ice once formed when Mars' axis tilted more sharply away from the sun than it does now. Related Stories: — Mars: Everything you need to know about the Red Planet — Facts about ESA's Mars Express orbiter — What happened to all the water on Mars? Here's why the debate continues "The linear grooves indicate where boulders frozen into the base of a glacier were dragged along, gouging out the troughs visible today," ESA officials said in the statement. "Around the base of the crater's inner walls, we can see the smooth, tongue-shaped ends of rock-covered glaciers. These 'debris aprons' formed when ice mixed together with rocky debris along the crater walls during a period of glaciation, and slowly crept downslope." The crater's interior also exhibits a mix of rock knobs, mesas, channels and plains, believed to be remnants of a collapsed central peak. Dark volcanic ash covers much of the crater floor, while surrounding wrinkle ridges mark ancient lava flows. "This feature-rich crater has all the ingredients for exploring Mars' varied geological processes, giving us a tantalizing taste of its complex history," ESA officials said in the statement.
Yahoo
2 days ago
- Yahoo
LEADOPTIK Awarded Key Patents Across Three Continents
Strengthening Global IP Portfolio in Optical Imaging for Minimally Invasive Procedures SAN JOSE, Calif., June 6, 2025 /PRNewswire/ -- LEADOPTIK Inc., a Silicon Valley-based medical imaging company, today announced it has been awarded key patents for its proprietary optical probe across three continents: North America, Europe, and Asia. LEADOPTIK designs and manufactures optical probes for minimally invasive procedures, where two critical factors are essential: high-resolution imaging and a miniaturized form factor. High-resolution imaging enables real-time visualization of tissue microstructure, empowering clinicians with the insight needed to make more informed decisions—whether collecting biopsy samples, resecting tumor margins, or delivering therapies to targeted sites. Equally important is miniaturization. Space is at a premium during minimally invasive procedures, and LEADOPTIK's probe is designed with an exceptionally small footprint to navigate tight anatomical pathways without compromising performance. The company's innovation is powered by cutting-edge metasurface technology—flat optical components created through the fusion of nanofabrication and advanced optical design. Unlike traditional optics, metasurfaces enable ultra-thin, high-performance imaging systems that are ideal for integration into medical devices. These three newly granted patents underscore LEADOPTIK's leadership in medical imaging: U.S. Patent (#US11953698B1): Covers a novel device-level metasurface design that significantly extends imaging depth without sacrificing resolution. The patent was granted with 100% of its original claims—a testament to the novelty of LEADOPTIK's approach. European and Japanese Patents (PCT065237 & PCT029301): Protect both the current probe assembly method and alternative configurations that support expanded clinical applications. "Building robust and scalable medical devices is non-negotiable," said Reza Khorasaninejad, CEO and Co-founder of LEADOPTIK. "Our team has not only invented new optical designs but also developed novel methods of integrating them with semiconductor-grade manufacturing processes. These patents reflect our commitment to making next-generation imaging accessible, reliable, and globally protected." "Our intellectual property is the foundation of LEADOPTIK's competitive edge," said Dr. Jiang You, Co-Founder and VP of Medical Imaging. "These patents not only protect our unique optical architecture but also validate the deep technical innovation required to miniaturize high-resolution imaging. It's a major milestone that strengthens our ability to scale globally and expand into new clinical applications." About LEADOPTIK LEADOPTIK is a Silicon Valley-based company pioneering AI-enhanced real-time optical imaging at the point of biopsy. By integrating high-resolution microstructural visualization with emerging analytics, the LIA system bridges the gap between diagnosis, and therapy, supporting more precise and informed decision-making in interventional pulmonology and beyond. For more information, visit Media Contact:hello@ View original content: SOURCE LEADOPTIK Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data